Short answer · Medically reviewed summary · Last updated: 2026-04-07
Mowat-Wilson syndrome is a rare genetic disorder characterized by a distinct facial appearance, intellectual disability, and various congenital anomalies. It is primarily referred to as Mowat-Wilson syndrome in modern medical literature, though historically it has been known by several eponymous names, including Goldberg-Shprintzen syndrome (in some older contexts) or ZEB2-related intellectual disability syndrome. What are the historical and alternative names for Mowat-Wilson syndrome? Before the genetic cause of Mowat-Wilson syndrome was identified, the condition was often described by its clinical symptoms, leading to various names in medical literature.
1 people with Mowat-Wilson syndrome have shared their first-person experience on this question at DiseaseMaps.
Mowat-Wilson syndrome is a rare genetic disorder characterized by a distinct facial appearance, intellectual disability, and various congenital anomalies. It is primarily referred to as Mowat-Wilson syndrome in modern medical literature, though historically it has been known by several eponymous names, including Goldberg-Shprintzen syndrome (in some older contexts) or ZEB2-related intellectual disability syndrome.
Before the genetic cause of Mowat-Wilson syndrome was identified, the condition was often described by its clinical symptoms, leading to various names in medical literature. You may encounter terms such as "Mental retardation-seizures-hypothyroidism-absent corpus callosum syndrome" or "Microcephaly-mental retardation-distinctive facial features syndrome." Because the syndrome was identified by Dr. David Mowat and Dr. Meredith Wilson in 1998, it was previously sometimes conflated with other syndromes involving Hirschsprung disease. It is important to note that while "Goldberg-Shprintzen syndrome" was sometimes associated with similar symptoms, it is now considered a distinct entity, and Mowat-Wilson syndrome should be distinguished from it based on the specific ZEB2 gene mutation.
The naming of Mowat-Wilson syndrome has evolved significantly due to the transition from descriptive clinical naming to genetic classification. In the past, doctors named syndromes after the clusters of symptoms they observed. As our understanding of the human genome improved, the condition was reclassified based on its underlying cause: a mutation or deletion of the ZEB2 gene. This shift is why you might see Mowat-Wilson syndrome referred to in genetic databases as "ZEB2-related neurodevelopmental disorder." Using the official eponymous name is currently the standard for clinical communication, as it ensures consistency across international medical records.
To help navigate medical literature, it is useful to know how Mowat-Wilson syndrome is indexed in global registries. Standardized classification systems help researchers and clinicians communicate effectively:
For the 111 members of the DiseaseMaps.org community living with Mowat-Wilson syndrome, using the correct name is vital for accessing specialized care and clinical trials. Medical professionals prefer "Mowat-Wilson syndrome" because it is a globally recognized eponym that links directly to the clinical phenotype—such as microcephaly, epilepsy, and Hirschsprung disease—that defines the patient experience. If you find older documents or confusing terminology in your medical history, it is recommended to clarify with your geneticist that the diagnosis is confirmed via ZEB2 molecular testing.
Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.